These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 11963197)
1. Evaluation of the risk factors for the failure of a single prophylactic dose of anticholinergic drugs for irinotecan-induced cholinergic symptoms. Watanabe T; Saito Y; Takekuma Y; Shimizu Y; Kinoshita I; Komatsu Y; Sugawara M Int J Clin Pharmacol Ther; 2024 May; 62(5):213-221. PubMed ID: 38431832 [TBL] [Abstract][Full Text] [Related]
2. Characterization of methanthelinium binding and function at human M Irmen M; Holze J; Bödefeld T; Tränkle C Naunyn Schmiedebergs Arch Pharmacol; 2018 Oct; 391(10):1037-1052. PubMed ID: 29938305 [TBL] [Abstract][Full Text] [Related]
3. [Randomized, placebo-controlled, double blind clinical trial for the evaluation of the efficacy and safety of oral methantheliniumbromide (Vagantin) in the treatment of focal hyperhidrosis]. Hund M; Sinkgraven R; Rzany B J Dtsch Dermatol Ges; 2004 May; 2(5):343-9. PubMed ID: 16281522 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial. Müller C; Berensmeier A; Hamm H; Dirschka T; Reich K; Fischer T; Rzany B J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1278-84. PubMed ID: 23004926 [TBL] [Abstract][Full Text] [Related]
10. Use of Systemic Therapies to Manage Focal Hyperhidrosis. Glaser DA; Glaser K Mo Med; 2015; 112(4):287-91. PubMed ID: 26455059 [TBL] [Abstract][Full Text] [Related]
11. Glycopyrronium (Qbrexza) Topical Wipes for Hyperhidrosis. Arnold MJ; O'Connor C Am Fam Physician; 2019 Sep; 100(6):372-373. PubMed ID: 31524358 [No Abstract] [Full Text] [Related]